Information on the carcinogenic potential of chemicals is primarily available for High Production Volume (HPV) products. Because of the limited knowledge gain from routine cancer bioassays and the fact that HPV chemicals are tested only, there is the need for more cost-effective and informative testing strategies. Here we report the application of advanced genomics to a cellular transformation assay to identify toxicity pathways and gene signatures predictive for carcinogenicity. Specifically, genomewide gene expression analysis and quantitative real time polymerase chain reaction (qRT-PCR) were applied to untransformed and transformed mouse fibroblast Balb/c 3T3 cells that were exposed to either 2, 4-diaminotoluene, benzo(a)pyrene, 2-acetylaminoflourene, or 3-methycholanthrene at IC20 conditions for 24 and 120 h, respectively. Then, bioinformatics was applied to define toxicity pathways and a gene signature predictive of the carcinogenic risk of these chemicals. Although bioinformatics revealed distinct differences for individual chemicals at the genelevel pathway, analysis identified common perturbation that resulted in an identification of 14 genes whose regulation in cancer tissue had already been established. Strikingly, this gene signature was identified in short-term (24 and 120 h) untransformed and transformed cells (3 weeks), therefore demonstrating robustness for its predictive power. The developed testing strategy thus identified commonly regulated carcinogenic pathways and a gene signature that predicted the risk for carcinogenicity for three well-known carcinogens. Overall, the testing strategy warrants in-depth validation for the prediction of carcinogenic risk of industrial chemicals in in vitro carcinogenicity assay.
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It has been estimated that more than 100,000 chemicals are in use that have not been tested for their safety. With new policy in place such as Registration, Evaluation, and Authorization of Chemical Substances (REACH), a large number of so far insufficiently characterized substances will need to be tested within a short time. Notably, the Organisation for Economic Cooperation and Development (OECD) testing strategies would necessitate unprecedented large number of animal testing. However, the limited knowledge gain from such studies and the significant uncertainties regarding hazard identification will hamper appropriate risk evaluation. Therefore, international programs such as the ToxCast Project and other alternative testing strategies had been initiated to obtain more meaningful data that is beyond the limited information gathered from OECD guideline studies. Indeed, nearly 500 assays that focus particularly on pathway perturbations had been developed (Judson et al., 2010) .
With more emphasis than the hitherto existing chemicals legislation, the use of innovative testing strategies is stipulated to provide information at the cell biology and molecular level (Combes et al., 2003) . The decisive criterion for them to be used is that they must yield reliable data for prediction of hazardous substance properties, such as the carcinogenic potential.
In this regard, cell transformation assays provide specific evidence for the tumorigenic potential of a substance, which cannot be defined by genotoxicity testing alone. Rodent cell transformation assays have thus been developed that exhibit sensitivity and specificity for predicting chemical carcinogens and are suitable for validation to foster regulatory acceptance (Kirkland et al., 2005) . This may include the Syrian hamster embryonic cell transformation assay and immortalized fibroblast cell lines. Thus, cell cultures are exposed to carcinogens and assessed for their ability to form foci of morphologically transformed cells. Notably, over half of all chemical-induced carcinogenesis in rodents appears to be nongenotoxic in origin but have proven more difficult to be predicted accurately in short-term assays (EllingerZiegelbauer et al., 2009 ).
Here we report the application of toxicogenomics to a cell transformation assay for accelerated testing of chemicals where a gene signature had been identified that appeared to be useful for the cost-effective and robust testing of chemicals.
MATERIALS AND METHODS
Chemicals. 2, 4-Diaminotoluene (DAT), benzo(a)pyrene (BaP), 2-acetylaminoflourene (AAF), and 3-methycholanthrene (MCA) were obtained from Sigma-Aldrich.
Cell cultures. The mouse fibroblast Balb/c 3T3 cell line was obtained from Cytotest Cell Research GmbH (RCC, Roßdorf, Germany). Cells were harvested and used within 9-10 passages to perform the experiments. Cells were cultured with M10F containing minimum essential medium þ 10% fetal bovine serum and incubated at 37°C and 5% CO 2 .
Cell treatment. Balb/c 3T3 cells were seeded at 200 cells in each 60-3 15-mm culture dish with 4 ml M10F, using six culture dishes for every treatment. Upon a confluence of 60-65%, the culture medium was removed and replaced with fresh medium containing the tested chemicals at defined concentrations, whereas the treatment of cells was for 24 and 120 h.
Specifically, the cytotoxicity was tested in two independent experiments with Experiment 1 employing concentrations that were based on published data, whereas in Experiment 2 a more refined approach was taken (see Supplementary fig. S1 and table S1). A summary of the two independent toxicogenomic experiments is given in Table 1. MTS (3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt) assay and cell viability. Cellular toxicity was determined with the MTS cell viability assay according to the manufacturer's instructions (Promega, Mannheim, Germany). The viability of treated Balb/c 3T3 cells was also tested using the trypan blue exclusion test prior to and after treatment of cells. Notably, the cytotoxicity differed after single (24 h) and repeated treatment (120 h). Individual data are shown in Supplementary figure S1, whereas Balb/c 3T3 cells treated with 0.75% (vol/ vol) dimethyl sulfoxide (DMSO) served as controls. Each experiment was repeated in triplicate.
In vitro transformation assay. The cellular transformation assay was carried out to examine the carcinogenic potential of chemicals and to verify some of the regulated genes by quantitative real time polymerase chain reaction (qRT-PCR). Essentially, Balb/c 3T3 (clone A31-1-1-1) cells were seeded at a density of 2 3 10 3 cells per 100-mm dish in 10 ml of culture medium. Twenty-four hours after seeding, cells were treated with either 15lM MCA or 3.17lM BaP for 72 h. Subsequently, the cells were cultured in normal medium for additional 21 days. The medium was changed twice a week for the duration of the assay. Visible morphologically transformed foci were harvested. After centrifugation, the supernatant was discarded, and the cell pellet was resuspended in 350-ll RNeasy Lysis buffer (RNeasy Mini Kit; Qiagen, Santa Clarita, CA) with b-mercaptoethanol for RNA extraction.
Extraction of total RNA. RNA was extracted with the RNeasy Mini Kit (Qiagen) according to the manufacturer's instruction. Samples were quantified using standard spectrophotometry and considered acceptable if the absorption ratio of 260/280 ratio was > 1.8. The quality of the total RNA was studied with the Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). Samples were accepted for further studies if the ribosomal 28S and 18S RNA bands were present.
Sample preparation for analysis with Affymetrix GeneChip System. Total RNA (5 lg) was used to generate biotin-labeled complementary ribonucleic acid (cRNA) (10 lg) by means of GeneChip One-Cycle cDNA Synthesis Kit and GeneChip IVT Labeling Kit (Affymetrix). Sample processing was performed exactly as described by the microarray manufacturer (Affymetrix). Quality control of cRNA was performed using a Bioanalyzer (Agilent 2001 Biosizing; Agilent Technologies). Following fragmentation, labeled cRNA of each sample was hybridized to Affymetrix GeneChip Mouse Genome-430 2.0 Arrays covering approximately 36,000 full-length mouse gene transcripts and stained according to the manufacturer's instructions. The arrays were scanned using the GeneChip Scanner 3000. The full description of the extraction protocol, labeling and hybridization protocol, and data processing are obtainable in the GEO DATA base under http://www.ncbi.nlm.nih.gov/geo/ (accession number GSE 22180).
Statistical analysis. Array data were normalized using scaling or per-chip normalization to adjust the total or average intensity of each array to be approximately the same. The scale factor (SF) was according to the Affymetrix recommended setting SF ¼ 1, and the mean target intensity value was 500 and were used to generate a microarray quality control and data report. A t-test analysis was performed using Data Mining Tool 3.0 from Affymetrix. A stringent comparison between the control and treatment groups was performed according to the consistency of gene expression changes. A t-test and a ranking analysis with up-and downregulated genes were performed, and only genes that exhibit a 100% concordance in the change direction with a p value < 0.05 (t-test) and a fold change (FC) ! 2/FC À 2 were reported. Duplicated probe sets were removed and the ones with the highest FC were kept. Bioinformatics analysis. Raw probe level data files exported from GeneChip Operating Software were uploaded into the ArrayTrack software (National Centre for Toxicological Research, U.S. FDA, Jefferson, AR). Principal component analysis (PCA) was carried out with the PCA tool implemented in the software ArrayTrack 3.4.5. (http://www.fda.gov/nctr /science/centers/toxicoinformatics/ArrayTrack/) with log-scaled gene expression intensities for all probe set IDs. Hierarchical cluster analysis (HCA) was carried out with the cluster tool implemented in the software ArrayTrack, using the Ward's algorithm to build the cluster tree.
Lists of significantly differentially expressed genes were uploaded to MetaCore (GeneGO, http:trials.genego.com), and functional annotation and pathway analysis were performed. Additionally, Venn diagrams were used to examine the overlap of resulting lists of genes differentially expressed between the different sample sets.
Quantitative real-time PCR. Validation of individual gene expression data was achieved by real-time PCR using the ABI PRISM 7500 Sequence Detection System Instrument (Applied Biosystems, Applera Deutschland GmbH, Darmstadt, Germany). Total RNA (200 ng) underwent reverse transcription using an Omniscript RT Kit (Qiagen) according to the manufacturer's instruction. PCR reactions were performed according to the instructions of the manufacturer using commercially available assays-on-demand (Applied Biosystems, Applera Deutschland GmbH). The assays used are Aspn (Mm00445945_ml), collagen, type V, alpha 2 (Col5a2) (Mm00483675_ml), Cyp1a1 (Mm00487218_ml), epiregulin (Ereg) (Mm00514794_ml), Fmod (Mm03003616_sl), Gpc1 (Mm00497305_ml), IL12rb1 (Mm00434189_ml), neural cell adhesion molecule 1 (Ncam1) (Mm03053534_sl), olfactomedin 1 (Olfm1) (Mm00444668_ml), Ptgs2 (Mm01307334_gl), receptor tyrosine kinase-like orphan receptor 1 (Ror1) (Mm00443462_ml), Tiparp (Mm00724822_ml), cysteine-rich, angiogenic inducer, 
RESULTS
Initially, published data were used to determine cytotoxicity in untransformed cell cultures. Here four different concentrations and two time points (24 and 120 h) were investigated. Based on the MTS assay conditions approximating IC20 could be defined for some of the chemicals tested. In a second study, a more refined approach was taken and included additional concentrations and two time points (24 and 120 h). Essentially, the cytotoxicity of individual chemicals differed after single (24 h) and repeated treatment (120 h). Individual data are shown in Supplementary figure S1, whereas Balb/c 3T3 cells treated with 0.75% (vol/vol) DMSO served as controls. Notable, each experiment was repeated at least in triplicates, and subsequent toxicogenomic studies were carried out at two different concentrations and time points at approximately IC20 conditions.
Gene Expression Data Analysis
PCA and Hierarchical Gene Cluster Analysis. PCA was applied to search for major differences among the various experiments. Figure 1a depicts the PCA applied to all experiments. Here, time point differences were larger than the effects observed after treatment with the chemicals. The score plot is given in Figure 1b and describes the results after 24 h of treatment with the various chemicals. Note, BaP, DAT, and MCA are clearly separated from the control (0.75% DMSO), but there was no significant separation between cells treated with 20lM MCA and 1.5lM BaP. After 120 h of treatment, BaP, MCA, and 50lM DAT are clearly separated (Fig. 1c) . The differentially expressed genes (mean channel intensity > 100, false discovery rate [FDR]: 0.05) between the initial groups were subjected to the Ward's Minimum Variance linkage clustering algorithm which revealed that 235 differentially expressed genes grouped together. A clear segregation of the different time points of the analyzed data was obtained (Fig. 2) . Only at the higher concentration of BaP, DAT, and MCA, distinct groups are visible.
Significant Regulated Genes in Treated Cells
All data from the two different experiments were subjected to a stringent comparison. A t-test and a ranking analysis with up-and downregulated genes were done, and only genes exhibiting a 100% concordance in the changed direction with a p value < 0.05 (t-test) and an FC ! 2/FC À2 are reported. FC values were calculated as the ratio of the average expression levels for each gene between exposure to each chemical and the corresponding control experiments. The regulated genes are given in Supplementary tables S2-S5 (see table S2 ¼ DAT,  table S3 ¼ BaP, table S4 ¼ MCA, and table S5 ¼ AAF) .
To investigate genes commonly regulated by BaP, DAT, and MCA, their intersection was analyzed and contained 41 genes regulated in common after 120 h of treatment (see Fig. 3 and Supplementary figs. S2 and S3 for the 24-h time point).
The significantly regulated genes were functionally categorized using GeneGO (http:trials.genego.com) and were grouped according to their functions, that is, immune response, cell cycle, transcription, metabolism, cell adhesion, proliferation, apoptosis, and their networks (Supplementary fig. S4 ).
Genes Commonly Regulated by BaP, DAT, and MCA As depicted in Figure 3 , and unlike DAT, most genes were regulated by BaP and MCA in terms of xenobiotic defense and included cytochrome P4501A1 and Cyp1b1, NAD(P)H dehydrogenase, quinone 1, xanthine dehydrogenase, and aldehyde 3 dehydrogenase A1, whereas other regulated genes coded for extracellular matrix remodeling. The latter may modulate signaling events that are frequently altered in carcinogenesis, to impact actin cytoskeletal dynamics, vessel trafficking, angiogenesis, cell proliferation, survival, differentiation, as well as motility, apoptosis, and cellular growth.
Genes Regulated by Chemicals after Treatment for 24 h
Cell cultures treated with BaP and MCA displayed changes in immune response, growth regulation, and cell adhesion and included repressed expression of interferon-regulated proteins such as interferon-induced protein with tetratricopeptide repeats 1 and interferon-induced protein 44, whereas certain chemokines participating in the activation of T cells, that is, chemokine (C-C motif) ligand 5 were induced. Already after single treatment of cell cultures, regulation of genes was observed that had been suggested as marker for early stages of carcinogenesis, namely alpha-fetoprotein in BaP-and DATtreated cells as well as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-inducible poly(ADP-ribose) polymerase.
Overall 17% of the regulated genes in MCA-and DATtreated cell cultures are involved in carcinogenesis activating signaling pathways and included oncogenes, extracellular matrix, and cell adhesion molecules that were regulated in common.
Genes specifically altered by treatment of DAT are tumor suppressor genes, including Ras association (RalGDS/AF-6) domain family 1, arrestin domain containing 3, cyclic adenosine monophosphate-responsive element binding protein-like 2, and B-cell translocation gene 2. Other genes regulated by DAT code for immune response leukemia inhibitory factor, histocompatibility 2, D region locus 1, complement component 1, TOXICOGENOMICS APPLIED TO IN VITRO CARCINOGENICITY s subcomponent, interferon gamma inducible protein 30, radical S-adenosyl methionine domain containing 2, and secretory leukocyte peptidase inhibitor. Note, inflammatory processes play an important role in carcinogenesis, whereas cell adhesion was another regulated process whose impairment can contribute to malignant transformation of cells and included adhesionregulating poliovirus receptor that was upregulated by DAT, where as gene expression of proteins directly involved in adhesion were downregulated, including sema domain, immunoglobulin domain 3C, and latrophilin 2.
Next, the growth arrest, and DNA damage-inducible gene Gadd45a was upregulated by DAT and BaP. Such a response can be mediated by activation of the p38/JNK pathway via the MTK1/MEKK4 kinase. Functional studies with Gadd45a revealed this protein to suppress growth in numerous cell types primarily through activation of the G2 checkpoint (Zhan et al., 1994) . Additionally, Gadd45a has been implicated in several cellular functions, including MAPK signaling, cell cycle regulation, DNA repair and genomic stability, apoptosis, and immune response. Defects in any one of these processes may contribute to cancer. A summary of regulated genes is given in Supplementary tables S2-S4 (see 
Genes Regulated by Chemicals after Treatment for 120 h
The most remarkable differences between BaP and MCA were observed in the immune response and in genes of the cell cycle (Supplementary fig. S2 ). For example, coactosin-like 1 was repressed. This gene encodes one of the actin-binding proteins to regulate the actin cytoskeleton and binds to F-actin; it also interacts with 5-lipoxygenase, which is the first committed enzyme in leukotriene biosynthesis, whereas Adamts 2, a disintegrin-like and metallopeptidase with thrombospondin type 1 motif, as well as Adamts 12 were downregulated. Furthermore, a strong induction of matrix metallopeptidase (Mmp) 13 and Mmp3 was observed after treatment with MCA (5.7-fold and 51.4-fold) and DAT (3-fold and 30-fold), suggesting an increase in proteolytic activity of extracellular matrix proteins. However, Mmp13 was repressed by BaP (threefold), whereas alcohol dehydrogenase 7 (Adh7) was upregulated that functions as retinol dehydrogenase to modulate cellular differentiation. Overall, repression of the defense and innate immune response and of genes participating in extracellular matrix remodeling, cell adhesion, and proteolysis were observed.
BaP also modulated genes associated with protection against oxidative stress, extracellular matrix, cell adhesion, and growth control and included HtrA serine peptidase 1, phospholipase A2,
FIG. 2.
Result of the HCA. The normalized data were used for the Ward's Minimum Variance linkage clustering algorithm. A total of 235 differentially expressed genes (mean channel intensity > 100, FDR: 0.05) were used in the cluster dendogram. Expression values were color coded with a red green scale. Green, transcript levels below the median; black, equal to the median; and red, greater than median.
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and A-kinase anchor protein 9. Notably, Htra1 encodes a member of the trypsin family of serine proteases and was shown when overexpressed in human cancer cells to inhibit cell growth and proliferation in vitro and in vivo, therefore suggesting a possible role as a tumor suppressor (Esposito et al., 2006) .
Treatment of cell cultures with MCA repressed immune response including interferon-induced proteins with tetratricopeptide repeats 1 and 3, interferon-induced protein 27 and 44, and chemokine (C-C motif) ligand 5. Likewise, MCA treatment was associated with reduced expression of cellmatrix adhesion molecules, that is, periostin and SPARC-like 1 that have been associated with tumor growth and metastasis. Repressed expression of periostin was observed in a variety of human cancer cell lines and periostin may play a role as a suppressor of invasion and metastasis in the progression of cancers (Kim et al., 2005) . A summary of the regulated genes is given in Supplementary  tables S2-S4 (see table S2 ¼ DAT, table S3 ¼ BaP, table S4 ¼  MCA) .
Notably, we also observed an upregulation of accepted cancer stem cell marker such as discs, large homolog 7 (Dlg7) in cells treated for 120 h at the higher concentrations of MCA, DAT, and BaP. Moreover, in DAT-and MCA-treated cells, CD34 was also upregulated while specifically with MCA CD44 expression was induced (Supplementary table S6) .
A Common Gene Signature among Different Carcinogens
Based on various comparisons, a common intersection among the differentially expressed genes could be defined that consisted of 41 regulated genes (see Fig. 3 and Supplementary  fig. S2 ). Notably, with the exception of Sema5a and Mmp13, all genes were regulated in common among DAT, BaP, and MCA, whereas treatment of cells with AAF had little or no effect. Differentially expressed genes were selected for further validation when regulated at both time points, that is, after 24 and 120 h of treatment. Overall, the gene signature consists of 14 highly regulated genes with established roles in tumorigenesis.
Identification of Morphologically Transformed Cells
To investigate cellular transformation, BALB/c 3T3 cells were treated with either 15lM MCA or 3.17lM BaP for 72 h. Three weeks later morphologically visible transformed foci (Fig. 4) were observed on the basis of the following characteristics: dense multilayering of cells, random cell orientation at all parts of the focus edge, invasion into the surrounding contact-inhibited monolayer, and domination of spindle-shaped cells. Note foci of less than 2 mm in diameter were not harvested (see also Schechtman, 1985) . 
Validation of the Gene Signature in Altered Foci by qRT-PCR
The gene signature consists of 14 highly regulated genes with established roles in tumorigenesis and consisted of glypican-1, prostaglandin-endoperoxide synthase 2, interleukin 12 receptor, beta 1, epiregulin, procollagen, type V, alpha 2, Cyp1a1, asporin, olfactomedin 1, cysteine-rich protein 61, TCDD-inducible poly(ADP-ribose) polymerase, neural cell adhesion molecule 1, cadherin 13, receptor tyrosine kinase-like orphan receptor 1), and fibromodulin.
Notably, a total of n ¼ 4 independent cell transformation assays were studied by real-time qRT-PCR and a comparison of FCs determined by microarray analysis and real-time qRT-PCR are given in Figures 5 and 6 , respectively. With the exception of Cyp1a1, there was good agreement between both methods even though the level of altered expression may vary.
DISCUSSION
The process of evaluating the safety of chemicals is inefficient, costly, and of limited value for risk assessment, and in the context of the EU-REACH program, it has been estimated that some 30,000 compounds have to be tested for safety. Based on OECD guidelines this would necessitate an additional 12 million animals. The level of information derived from these studies is, at best, limited. There is a pressing need for alternative testing strategies that predict chronic toxicity and tumorigenicity, based on mode of action for different classes of chemicals and through an assessment of perturbed pathways, as attempted in the Tox21 initiative (Kavlock et al., 2009) . Thus, more relevant information to human health will then become available and would ultimately result in improved strategies for hazard identification and risk assessment to improve the well-being of citizens. In particular, predicting carcinogenicity represents a problem which, as yet, could not be solved satisfactorily (Hagmar et al., 1998) , and the use of transgenic animal models failed so far to meet expectations (Sills et al., 2001) . Specifically, biochemical end points, as compared with the traditional cancer bioassay end points, offer the advantage of yielding information about the mechanisms of action. In this regard the application of genomic sciences to toxicity testing is a major break through and basically combines genome-wide messenger ribonucleic acid (mRNA) expression profiling with protein expression patterns and metabolite fingerprints using bioinformatics to understand the role of gene chemical interactions in disease and organ dysfunction (Borlak, 2005) .
Consequently, toxicogenomics carries the hope to provide more meaningful data and therefore was applied to an in vitro carcinogenicity assay. Here, several genes were identified that were modulated by more than one chemical tested, and if so, their expression was changed in the same direction. The functional overlap of modulated genes between the different treatments was reassuring. Notably, most transcriptomic changes were observed in cells treated with DAT, BaP, and MCA, whereas AAF did not cause any change. Similar cellular processes appeared to be regulated by these chemicals, and even if individual genes might differ in their regulation they still belong to the same pathways. For example, BaP, DAT, and MCA modulated the expression of various cell-cell and cell-matrix adhesion molecules. Likewise genes coding for immune response were commonly regulated. A notable finding was the concentration-dependent increase in differential gene expression that was evident for both time points when treated with either MCA or DAT, whereas for BaP, this effect was only obvious after 120 h (Supplementary  fig. S5 ). Overall, studies were done at mild conditions, that is, low acute toxicity (at IC20), and many genes were commonly regulated at both concentrations, that is, 40% of the genes regulated by 1.5lM BaP were already regulated by 0.5lM BaP (Supplementary figs. S4 and S5) .
Based on various bioinformatics comparisons, a common intersection among the differentially expressed genes could be defined that consisted of 41 regulated genes (Supplementary fig. S2 ). Notably, with the exception of sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A (Sema5a) and MMP13, all genes were regulated in common among DAT, BaP, and MCA, whereas treatment of cells with AAF had little or no effect. Furthermore, a concentration-dependent regulation of genes was observed as shown in Figures 2 and 3 . Differentially expressed genes were selected for further validation when regulated at both time points, that is, after 24 and 120 h of treatment. Overall, the gene signature consists of 14 highly regulated genes with established roles in tumorigenesis.
Their regulation was confirmed by real-time qRT-PCR in transformed Balb/c 3T3 cells which were harvested 3 weeks after initial MCA and BaP treatment for 72 h. Note, the transformed cells formed colonies (Fig. 4) . Thus, regulation of these genes persisted in transformed cells, whereas their identification was already obvious in untransformed cells. The similar regulation in untransformed and transformed cells supports their functional importance. Indeed, genes such as Ereg (Rohrbeck et al., 2009) , Ptgs2 (Lo et al., 2010) , Cdh13 (Jin et al., 2008) , and Ncam1 (Schröder et al., 2009) had repeatedly been associated with carcinogenesis. For instance, induction of Ptgs2, also known as cyclooxygenase-2 (COX-2), in response to treatment of Balb/c 3T3 cells with DAT, BaP, and MCA had been observed in a variety of cancers, mainly of the gastrointestinal tract (Shamma et al., 2000) and was associated with increased proliferation, reduced apoptosis (Lo et al., 2010) , stimulation of angiogenesis (Jones et al., 1999) , and invasive or metastatic spread (Tsujii et al., 1997) . It was also reported that Ptgs2 is subjected to epigenetic regulation in gastric and colorectal cancer, but this resulted in transcriptional repression (Kang et al., 2003) . Moreover, Aspn (asporin), a cartilage extracellular protein was shown to interact with and to inhibit transforming growth factor beta signaling. Increased expression of Aspn mRNA was detected in breast cancer (Turashvili et al., 2007) and in prostate cancer cells (Best et al., 2005) . Next, stromal expression of Col5a2 is associated with malignancy in colorectal cancer and was shown to be increased in adenoma-derived dysplastic epithelial cells (Guillen-Ahlers et al., 2008) . Recently, it was reported that the heparan sulfate proteoglycan glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells (Aikawa et al., 2008) , whereas Cyr61 is involved in neurofibromatosis type 1 tumorigenesis (Pasmant et al., 2010) and is overexpressed in esophageal squamous cell carcinoma (Zhou et al., 2009) . Also Olfm1 was upregulated in the endometrial cancer (Wong et al., 2007) and in synovial sarcomas (Allander et al., 2002) , whereas fibromodulin is a novel tumor-associated antigen in chronic lymphocytic leukemia (Mayr et al., 2005) as is Ror1, a cell-surface receptor tyrosine kinase that is expressed in chronic lymphocytic leukemia (Daneshmanesh et al., 2008) . Furthermore, it was demonstrated that Ror1 is a receptor for wingless-related MMTV integration site 5A (Wnt5a), a cancer-associated gene involved in invasion and metastasis of melanoma, breast cancer, pancreatic cancer, and gastric cancer (Katoh and Katoh, 2009) . Regulation of Tiparp is also considered as marker of early stages of carcinogenesis (Peralta-Leal et al., 2008) . Taken collectively, the gene signature can be linked to various cancers and have been associated specifically, with early tumor progression and metastasis.
A perplexing finding was the regulation of Cyp1a1 mRNA which was highly significantly upregulated among all chemicals tested at 120 h. Indeed, the coded protein is essential in xenobiotic defense but also catalyses metabolic activation of polycyclic aromatic hydrocarbons to carcinogens that readily react with DNA to cause adducts and gene mutations that ultimately results in cellular transformation (Nebert and Dalton, 2006) . Importantly, we could not detect Cyp1a1 by qRT-PCR in altered cell foci that were harvested 3 weeks after the last treatment with MCA and BaP. This is, however, of no surprise as it is known that MCA induces Cyp1a1 in rodent (Riddick et al., 1994) and human hepatoma cell lines for short periods of time only (4-36 h) with Cyp1a1 mRNA being degraded at a half-life of 2.4 h (Lekas et al., 2000) . Moreover, in rats, a single dose of MCA (20-25 mg/kg) induced Cyp1a1 mRNA expression after 24 h and return to normal within 5-7 days (Bresnick et al., 1981) . Although for some CYPs induction might persist for 2-3 weeks (see DePierre et al. [1982] ), a recent study evidenced induction of Cyp1a1 activities after MCA treatment for up to 96 h (Fazili et al., 2010) . Taken collectively, the discrepancies between microarray and qRT-PCR of altered cell foci is simple a reflection of the half-life of Cyp1a1 mRNA.
Finally, the data obtained in the present study were also compared with previously published microarray studies. As a result, 81 genes were identified as common regulated when compared with the results reported by Mathijs et al. who investigated genotoxic and nongenotoxic carcinogens by gene TOXICOGENOMICS APPLIED TO IN VITRO CARCINOGENICITY expression profiling of primary mouse hepatocytes (Mathijs et al., 2009) . Similarly 128 genes intersected in such a comparison demonstrating reasonable concordance among different studies. In a microarray study using MCA-treated BALB/c mice, epiregulin was identified as a significantly upregulated transcript in tumors (Bauer et al., 2009) , which again agrees well with our in vitro data. Likewise, we could confirm Tiparp, Ror1, and Ereg by qRT-PCR, and lastly in a rat microarray study, a 112-gene classifier was defined for the discrimination of 30 chemicals (Uehara et al., 2008) . In such comparison, we found five genes regulated in common.
In conclusion, toxicogenomics applied to an in vitro carcinogenicity assays enabled an identification of a gene signature that is likely to be predictive for chemical carcinogens. Although only a small set of chemicals was tested, the findings warrant further development and full validation of such alternative testing strategy.
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